Bavarian Nordic A/S (OTCMKTS:BVNRY) Short Interest Up 55.9% in February

Bavarian Nordic A/S (OTCMKTS:BVNRY) was the target of a significant increase in short interest during the month of February. As of February 15th, there was short interest totalling 5,300 shares, an increase of 55.9% from the January 31st total of 3,400 shares. Based on an average trading volume of 24,500 shares, the short-interest ratio is presently 0.2 days.

Bavarian Nordic A/S Price Performance

BVNRY stock opened at $7.72 on Monday. The company has a market cap of $1.83 billion, a price-to-earnings ratio of 11.19 and a beta of 1.68. The company has a fifty day moving average price of $8.60 and a 200 day moving average price of $10.00. Bavarian Nordic A/S has a 12 month low of $6.86 and a 12 month high of $14.60.

About Bavarian Nordic A/S

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.